// App-Quantinova.ai

OC 10.5 : Plasma Protein Disulfide Isomerase Levels Predict Thrombosis in Myeloproliferative Neoplasms: A Prospective Cohort Study

Researchers

Presenter

  • A. Sharda

Principal Investigators

  • T. Bogue

  • A. Barr

  • R. Flaumenhaft

  • J. Zwicker

Medical Centers

  • Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Myeloid neoplasms

  • Congestive heart failure

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved